Symbols

JBIO

Jade Biosciences·NASDAQ

--(--)

8.64 / 10

Outperform

The fund flow profile scores 7.53/10, demonstrating robust fund flow characteristics. Favorable Medium movements are tempered by challenging overall, block, Small, Large, and Extra-large dynamics, supporting positive flow assessment. The analyst community expresses overwhelmingly bullish analyst consensus with strong conviction. Ratings composition: Strong Buy(75.0%), Buy(25.0%) representing 4 analyst views, supported by 9.76 historical weighted rating.

Fund Flow Rating

Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

75%

Buy

25%

Hold

Sell

Strong Sell

Date2026-03-25

InstitutionHC Wainwright & Co.

Times predicted2

Historical Win Rate100.0%

What is the analyst consensus for JBIO?

JBIO holds a Bullish analyst rating, with 75% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 8.64/10 (Outperform).